Medicare Enrolled
Dr. Penner Schraudenbach, MD
Urology Physician · Tomball, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Schraudenbach from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Schraudenbach? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Schraudenbach
Dr. Penner Schraudenbach is an urology physician in Tomball, TX, with 18 years in practice. Based on federal Medicare data, Dr. Schraudenbach performed 10,876 Medicare services across 2,904 unique beneficiaries.
Between the years covered by Open Payments, Dr. Schraudenbach received a total of $38,546 from 63 pharmaceutical and/or device companies across 590 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Schraudenbach is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice▲ Top 9% volume in TX$ $38,546 industry payments
Medicare Practice Summary
Medicare Utilization ↗10,876
Medicare services
Top 9% in TX for urology physician
2,904
Unique beneficiaries
$63
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~604 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) | 5,402 | $0 | $3 |
| Office visit, established patient (30-39 min) | 736 | $88 | $368 |
| Leuprolide injectable, camcevi, 1 mg | 672 | $55 | $248 |
| Infectious disease DNA/RNA test | 507 | $34 | $166 |
| Bladder ultrasound after voiding | 367 | $8 | $97 |
| Office visit, established patient (20-29 min) | 363 | $66 | $250 |
| Automated urinalysis | 339 | $2 | $16 |
| Unclassified drugs | 338 | $386 | $1,017 |
| Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | 263 | $291 | $2,762 |
| Placement of hormone pellet under skin | 258 | $71 | $311 |
| Diagnostic exam of bladder and urethra using an endoscope | 186 | $183 | $684 |
| New patient office visit (45-59 min) | 181 | $112 | $565 |
| Insertion of implant in urethra within prostate gland using an endoscope, each additional implant | 132 | $706 | $3,366 |
| Detection test by nucleic acid for organism, quantification | 117 | $42 | $222 |
| Ct scan of abdomen and pelvis without contrast | 67 | $75 | $560 |
| Initial hospital admission, moderate complexity | 61 | $99 | $470 |
| Simple bladder irrigation and/or instillation | 55 | $59 | $296 |
| Hospital follow-up visit, moderate complexity | 51 | $63 | $247 |
| Electronic analysis of implanted neurostimulator generator with complex spinal cord or peripheral nerve stimulator programming | 45 | $43 | $221 |
| Insertion of sacral nerve neurostimulator electrode array | 41 | $875 | $7,618 |
| Insertion of peripheral or gastric neurostimulator generator | 41 | $69 | $1,176 |
| Yeast/candida DNA test | 39 | $34 | $123 |
| Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique | 39 | $34 | $182 |
| Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique | 39 | $34 | $153 |
| Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique | 39 | $34 | $153 |
| Detection test by nucleic acid for strep (streptococcus, group a), quantification | 39 | $41 | $146 |
| Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique | 39 | $34 | $123 |
| Simple insertion of temporary bladder tube | 37 | $49 | $343 |
| Ct scan of chest with contrast | 35 | $53 | $821 |
| CT scan of abdomen and pelvis with contrast | 35 | $179 | $1,067 |
| Detection test for gardnerella vaginalis (bacteria), quantification | 31 | $41 | $146 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 30 | $17 | $68 |
| Imaging of urinary tract following injection of a contrast agent | 28 | $19 | $61 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 26 | $21 | $145 |
| Crushing of stone of ureter with insertion of stent using an endoscope | 23 | $331 | $1,272 |
| Insertion of implant in urethra within prostate gland using an endoscope, 1 implant | 22 | $1,034 | $4,403 |
| Destruction of prostate tissue using radiofrequency induced heated water vapor | 21 | $1,348 | $5,628 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 19 | $310 | $1,205 |
| Electronic assessment of bladder emptying | 19 | $6 | $277 |
| Assessment of muscle signal of pelvic nerves | 19 | $110 | $747 |
| Insertion of device into abdomen with pressure and urine flow rate study | 19 | $156 | $522 |
| Biopsy of prostate gland | 19 | $196 | $775 |
| Ultrasonic guidance for needle placement | 19 | $47 | $633 |
| Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | 18 | $260 | $837 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.4% high complexity
55.0% medium
44.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$38,546
Total received (2018-2024)
Avg $5,507/year across 7 years
Top 7% in TX for urology physician
63
Companies
590
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$19,028 (49.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$17,252 (44.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,265 (5.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$3,935
2023$2,633
2022$5,317
2021$7,094
2020$1,670
2019$8,229
2018$9,667
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Astellas Pharma US Inc
$16,881
Axonics, Inc.
$6,714
Duchesnay USA Incorporated
$2,037
Medtronic, Inc.
$2,027
Boston Scientific Corporation
$1,639
PROCEPT BioRobotics Corporation
$1,136
Axonics Modulation Technologies, Inc.
$1,088
Sumitomo Pharma America, Inc.
$894
Coloplast Corp
$755
Myriad Genetic Laboratories, Inc.
$741
UROVANT SCIENCES INC
$621
BOSTON SCIENTIFIC CORPORATION
$577
Janssen Biotech, Inc.
$370
Medtronic USA, Inc.
$341
PFIZER INC.
$236
Endo Pharmaceuticals Inc.
$224
Olympus America Inc.
$211
ACCORD HEALTHCARE, INC.
$206
Antares Pharma, Inc.
$173
Dornier MedTech America, Inc
$138
Seagen Inc.
$122
Cook Incorporated
$117
Teleflex LLC
$72
Supernus Pharmaceuticals, Inc.
$65
180 Medical, Inc.
$63
Avadel Specialty Pharmaceuticals, LLC
$56
MEDIVATION FIELD SOLUTIONS LLC
$54
Agiliti Surgical, Inc.
$54
Allergan Inc.
$52
C. R. Bard, Inc. & Subsidiaries
$49
Kowa Pharmaceuticals America, Inc.
$44
ConvaTec Inc.
$44
BLUEWIND MEDICAL
$41
GENZYME CORPORATION
$39
Augmenix, Inc.
$38
Laborie Medical Technologies Corp.
$35
Palette Life Sciences, Inc.
$34
Tolmar, Inc.
$34
Clarus Therapeutics Inc.
$32
ARGON MEDICAL DEVICES, INC.
$32
Urgo Medical North America, LLC
$31
Progenics Pharmaceuticals, Inc.
$28
Bayer Healthcare Pharmaceuticals Inc.
$28
Ferring Pharmaceuticals Inc.
$27
Myovant Sciences Inc.
$26
Novartis Pharmaceuticals Corporation
$26
Abbott Laboratories
$24
Sun Pharmaceutical Industries Inc.
$24
Endo USA, Inc.
$20
CIVCO Medical Instruments
$20
Azurity Pharmaceuticals, Inc.
$20
Telix Pharmaceuticals
$19
Integra LifeSciences Corporation
$19
J&R Medical, LLC
$19
Cook Medical LLC
$18
TOLMAR Pharmaceuticals, Inc.
$17
NeoTract Inc.
$15
NxThera, Inc.
$15
Amgen Inc.
$14
TherapeuticsMD, Inc.
$14
Calyxo, Inc.
$13
AbbVie, Inc.
$12
Ambu Inc.
$8
Top 3 companies account for 66.5% of total payments
Associated products mentioned in payments ›
ADSTILADRIN · ALTIS · AMS · AMS 700 · AMS 700 CXR RTE KIT · AMS 700 CXR RTE Kit · AQUABEAM ROBOTIC SYSTEM · AVYCAZ · AZMIRO · Altis · Androgel · AquaBeam Robotic System · Axonics · Axonics r-SNM System · BOTOX · BOTOX THERAPEUTIC · BRAC CDx · BRACANALYSIS CDX · BRACAnalysis · BRACAnalysis CDx · Bard Urinary Drainage Bag · Bulkamid · CAMCEVI · COOK MEDICAL UROLOGY · CVAC ASPIRATION SYSTEM · Clot Management · DAKOTA · ELIGARD · ERLEADA · Erleada · GEMTESA · GENERAL BPH · GENERAL BPH · GENERAL KIDNEY STONE DISEASE · GENERAL - BPH · GENERAL ERECTILE DYSFUNCTION · GENESIS · GENTLECATH · GREENLIGHT · General - Kidney Stone Disease · ILLUCCIX · IMVEXXY · INTERSTIM · INTERSTIM ICON · Integra · JATENZO · JEVTANA · LITHOVUE · Lithotripters & Accessories · MYRBETRIQ · Myrbetriq · NCIRCLE · NOCDURNA · Noctiva · Nubeqa · ORGOVYX · Osphena · Otrexup · PADCEV · PLUVICTO · PROCLAIM · PROLARIS · PYLARIFY · Prolaris · Prolia · REVI · Rezum · Rezum Generator · SEGLENTIS · ShockPulse - SE · Sonablate HIFU · SpaceOAR · SpaceOAR VUE System - 10mL · SpeediCath · TACTRA · TITAN · TLANDO · TOROSA · TOVIAZ · UROLIFT · UroLift · UroLift System · VASHE WOUND SOLUTION 250 ML (8.5 FL OZ) FLIP TOP CAP · Veozah · XIAFLEX · XTANDI · XYOSTED · Xtandi · YONSA · ZYTIGA · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (49%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in urology physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 7% for urology physician in TX.
Equivalent to $354 per 100 Medicare services performed
Geographic Context
Urology Physicians within 10 mi
62
Per 100K population
1.3
County median income
$73,104
Nearest hospital
HCA HOUSTON HEALTHCARE TOMBALL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Schraudenbach is a mixed practice specialist, with above-average Medicare volume (top 9% in TX), and high industry engagement (speaking/promotional, top 7%), with 18 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Schraudenbach experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Schraudenbach performed 5,402 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Schraudenbach receive payments from pharmaceutical companies?
Yes. Dr. Schraudenbach received a total of $38,546 from 63 companies across 590 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Schraudenbach's costs compare to other urology physicians in Tomball?
Dr. Schraudenbach's average Medicare payment per service is $63. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Schraudenbach) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Tomball
Browse urology physicians in Tomball ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in TX
Urology Physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in TX
Which TX urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Axonics, Inc. Payments to Doctors
See all physicians who received payments from Axonics, Inc..
By company
Duchesnay USA Incorporated Payments to Doctors
See all physicians who received payments from Duchesnay USA Incorporated.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology